Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD)
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether methylphenidate is effective in enhancing the
cognitive performance of children with the HbSS or HbSC genotype of SCD who have sustained
neurological complications on laboratory-based measures of sustained attention, reaction
time, and executive functions, and indirectly, verbal short-term and long-term memory.